Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Roles of Shiga Toxins in Immunopathology.

Lee MS, Tesh VL.

Toxins (Basel). 2019 Apr 9;11(4). pii: E212. doi: 10.3390/toxins11040212. Review.

2.

Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.

Park JY, Jeong YJ, Park SK, Yoon SJ, Choi S, Jeong DG, Chung SW, Lee BJ, Kim JH, Tesh VL, Lee MS, Park YJ.

Toxins (Basel). 2017 Oct 13;9(10). pii: E319. doi: 10.3390/toxins9100319.

3.

Toxins: State of the Journal Report, 2017.

Xiao C, Tesh VL.

Toxins (Basel). 2017 Feb 4;9(2). pii: E55. doi: 10.3390/toxins9020055.

4.

Announcing the 2017 Toxins Travel Awards for Post-Doctoral Fellows and Ph.D. Students.

Tesh VL.

Toxins (Basel). 2017 Jan 17;9(1). pii: E37. doi: 10.3390/toxins9010037.

5.

Announcing the 2016 Toxins Travel Awards for Post-Doctoral Fellows and Ph.D. Students.

Tesh VL.

Toxins (Basel). 2016 Feb 6;8(2):41. doi: 10.3390/toxins8020041. No abstract available.

6.

Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications.

Lee MS, Koo S, Jeong DG, Tesh VL.

Toxins (Basel). 2016 Mar 17;8(3). pii: E77. doi: 10.3390/toxins8030077. Review.

7.

Shiga Toxins Activate the NLRP3 Inflammasome Pathway To Promote Both Production of the Proinflammatory Cytokine Interleukin-1β and Apoptotic Cell Death.

Lee MS, Kwon H, Lee EY, Kim DJ, Park JH, Tesh VL, Oh TK, Kim MH.

Infect Immun. 2015 Oct 26;84(1):172-86. doi: 10.1128/IAI.01095-15. Print 2016 Jan.

8.

Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Lee MS, Kim MH, Tesh VL.

J Microbiol. 2013 Dec;51(6):724-30. doi: 10.1007/s12275-013-3429-6. Epub 2013 Dec 19. Review.

PMID:
24385347
9.

Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Stearns-Kurosawa DJ, Oh SY, Cherla RP, Lee MS, Tesh VL, Papin J, Henderson J, Kurosawa S.

Am J Pathol. 2013 Apr;182(4):1227-38. doi: 10.1016/j.ajpath.2012.12.026. Epub 2013 Feb 10.

10.

Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells.

Leyva-Illades D, Cherla RP, Lee MS, Tesh VL.

Infect Immun. 2012 Jun;80(6):2109-20. doi: 10.1128/IAI.06025-11. Epub 2012 Mar 19.

11.

Coxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP-1 cells.

Zhang Y, Zhang G, Hendrix LR, Tesh VL, Samuel JE.

PLoS One. 2012;7(1):e30841. doi: 10.1371/journal.pone.0030841. Epub 2012 Jan 27.

12.

The induction of apoptosis by Shiga toxins and ricin.

Tesh VL.

Curr Top Microbiol Immunol. 2012;357:137-78. doi: 10.1007/82_2011_155. Review.

PMID:
22130961
13.

Activation of cell stress response pathways by Shiga toxins.

Tesh VL.

Cell Microbiol. 2012 Jan;14(1):1-9. doi: 10.1111/j.1462-5822.2011.01684.x. Epub 2011 Sep 22. Review.

14.

Shiga toxins induce autophagy leading to differential signalling pathways in toxin-sensitive and toxin-resistant human cells.

Lee MS, Cherla RP, Jenson MH, Leyva-Illades D, Martinez-Moczygemba M, Tesh VL.

Cell Microbiol. 2011 Oct;13(10):1479-96. doi: 10.1111/j.1462-5822.2011.01634.x. Epub 2011 Jul 4.

15.

Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.

Lentz EK, Leyva-Illades D, Lee MS, Cherla RP, Tesh VL.

Infect Immun. 2011 Sep;79(9):3527-40. doi: 10.1128/IAI.05139-11. Epub 2011 Jun 27.

16.

Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.

Lentz EK, Cherla RP, Jaspers V, Weeks BR, Tesh VL.

Infect Immun. 2010 Sep;78(9):3689-99. doi: 10.1128/IAI.00616-10. Epub 2010 Jul 6.

17.

Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by Shiga toxin type 1.

Lee MS, Cherla RP, Lentz EK, Leyva-Illades D, Tesh VL.

Infect Immun. 2010 Aug;78(8):3378-91. doi: 10.1128/IAI.00342-10. Epub 2010 Jun 1.

18.

Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.

Lee MS, Cherla RP, Tesh VL.

Toxins (Basel). 2010 Jun;2(6):1515-35. doi: 10.3390/toxins2061515. Epub 2010 Jun 17. Review.

19.

Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1.

Leyva-Illades D, Cherla RP, Galindo CL, Chopra AK, Tesh VL.

Infect Immun. 2010 Jun;78(6):2454-65. doi: 10.1128/IAI.01341-09. Epub 2010 Mar 29.

20.

Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.

Stearns-Kurosawa DJ, Collins V, Freeman S, Tesh VL, Kurosawa S.

Infect Immun. 2010 Jun;78(6):2497-504. doi: 10.1128/IAI.01435-09. Epub 2010 Mar 22.

21.

Induction of apoptosis by Shiga toxins.

Tesh VL.

Future Microbiol. 2010 Mar;5(3):431-53. doi: 10.2217/fmb.10.4. Review.

22.

Bcl-2 regulates the onset of shiga toxin 1-induced apoptosis in THP-1 cells.

Lee MS, Cherla RP, Leyva-Illades D, Tesh VL.

Infect Immun. 2009 Dec;77(12):5233-44. doi: 10.1128/IAI.00665-09. Epub 2009 Sep 14.

23.

Shiga toxin 1-induced proinflammatory cytokine production is regulated by the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway.

Cherla RP, Lee SY, Mulder RA, Lee MS, Tesh VL.

Infect Immun. 2009 Sep;77(9):3919-31. doi: 10.1128/IAI.00738-09. Epub 2009 Jul 13.

24.

Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells.

Lee SY, Lee MS, Cherla RP, Tesh VL.

Cell Microbiol. 2008 Mar;10(3):770-80. Epub 2007 Nov 13.

PMID:
18005243
25.

Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1.

Lee SY, Cherla RP, Tesh VL.

Infect Immun. 2007 Mar;75(3):1291-302. Epub 2006 Dec 28.

26.

Procalcitonin in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.

Decaluwe H, Harrison LM, Mariscalco MM, Gendrel D, Bohuon C, Tesh VL, Proulx F.

Pediatr Res. 2006 Apr;59(4 Pt 1):579-83.

PMID:
16549533
27.
28.

Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome.

Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL.

Am J Nephrol. 2005 Nov-Dec;25(6):536-40. Epub 2005 Sep 22.

PMID:
16179829
29.

Reduced nitric oxide bioavailability in a baboon model of Shiga toxin mediated hemolytic uremic syndrome (HUS).

Siegler RL, Pysher TJ, Tesh VL, Noris M, Cassis P, Taylor FB Jr.

Ren Fail. 2005;27(5):635-41.

PMID:
16153006
31.

Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells.

Harrison LM, Cherla RP, van den Hoogen C, van Haaften WC, Lee SY, Tesh VL.

Microb Pathog. 2005 Feb-Mar;38(2-3):63-76.

PMID:
15748808
32.

Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Harrison LM, van den Hoogen C, van Haaften WC, Tesh VL.

Infect Immun. 2005 Jan;73(1):403-12.

33.
34.

Shiga toxins and apoptosis.

Cherla RP, Lee SY, Tesh VL.

FEMS Microbiol Lett. 2003 Nov 21;228(2):159-66. Review.

35.

Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB.

Pediatr Nephrol. 2003 Feb;18(2):92-6. Epub 2003 Jan 10.

PMID:
12579394
36.

Prophylactic heparinization is ineffective in a primate model of hemolytic uremic syndrome.

Siegler RL, Pysher TJ, Tesh VL, Denkers ND, Taylor FB.

Pediatr Nephrol. 2002 Dec;17(12):1053-8. Epub 2002 Nov 8.

PMID:
12478357
37.

Renal prostacyclin biosynthesis in a baboon model of Shiga toxin mediated hemolytic uremic syndrome.

Siegler RL, Pysher TJ, Tesh VL, Taylor FB.

Nephron. 2002 Oct;92(2):363-8.

PMID:
12218315
38.

von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.

Pysher TJ, Siegler RL, Tesh VL, Taylor FB Jr.

Pediatr Dev Pathol. 2002 Sep-Oct;5(5):472-9. Epub 2002 Aug 29.

PMID:
12196894
40.

Shiga toxins--not just cytotoxins anymore.

Tesh VL.

Trends Microbiol. 2001 Dec;9(12):584-5. No abstract available.

PMID:
11728869
41.

Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome.

Siegler RL, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr.

Am J Nephrol. 2001 Sep-Oct;21(5):420-5.

PMID:
11684808
42.

Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome.

Siegler RL, Pysher TJ, Tesh VL, Taylor FB Jr.

J Am Soc Nephrol. 2001 Jul;12(7):1458-67.

44.

Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.

Ramegowda B, Samuel JE, Tesh VL.

J Infect Dis. 1999 Oct;180(4):1205-13.

PMID:
10479149
45.

Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.

Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL.

Am J Pathol. 1999 Apr;154(4):1285-99.

46.

Virulence of enterohemorrhagic Escherichia coli: role of molecular crosstalk.

Tesh VL.

Trends Microbiol. 1998 Jun;6(6):228-33. Review.

PMID:
9675799
49.
50.

Mutation of flgM attenuates virulence of Salmonella typhimurium, and mutation of fliA represses the attenuated phenotype.

Schmitt CK, Darnell SC, Tesh VL, Stocker BA, O'Brien AD.

J Bacteriol. 1994 Jan;176(2):368-77.

Supplemental Content

Support Center